ScholarWorks@Korea University College of Medicine: Kim, Min Ja

Detailed Information

Kim, Min Ja (김민자)

Anam Hospital (Department of Infectious Diseases, Anam Hospital)

Research Area: 신개념 항균 물질 개발, 레지오넬라 감염증과 면역, 폐렴구균 혈청형 및 백신 효과, Phage-derived antibacterial agents, Legionella pneumophila and Immune responses, Pneumococcal serotypes and vaccine effectiveness

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Legionella pneumophila:7||Safety:6||Bacteremia:5||Risk factors:5||Epidemiology:5||Legionella:5||Staphylococcus aureus:5||Korea:5||risk factors:4||Infection control:4||mortality:4||Communityacquired pneumonia:4||Streptococcus pneumoniae:4||epidemiology:4||Prognosis:3||Mortality:3||infection control:3||Klebsiella pneumoniae:3||Ertapenem:3||43017:3||Efficacy:3||Endocarditis:3||Extendedspectrum betalactamase:3||Legionnaires' disease:3||Candidemia:3||Leptospira:3||Hepatitis A:3||Methicillinresistant Staphylococcus aureus:3||Surgical site infection:3||Surveillance:3||Risk factor:3||Mycoplasma pneumoniae:3||Pulsedfield gel electrophoresis (PFGE):3||pneumonia:3||HIV:3||Antimicrobial susceptibility:2||Disease outbreaks:2||Candida:2||Phage typing:2||Communicable diseases:2||tuberculosis:2||heejin:2||Acute pyelonephritis:2||Gastric surgery:2||E. coli:2||Molecular epidemiology:2||Pneumococcal infections:2||Pneumonia:2||Molecular typing:2||Adult:2||Treatment outcome:2||Prosthesisrelated infections:2||Puldesfield gel electrophoresis:2||Genotype:2||Vancomycinresistant enterococci:2||ESBL:2||Gramnegative bacteria:2||Echinocandins:2||Mycobacterium abscessus:2||Mycobacterium tuberculosis:2||amphotericin B:2||Republic of Korea:2||Leptospirosis:2||Neurosurgery:2||Elderly:2||Lipoprotein:2||Ceftriaxone:2||Ribotyping:2||HFRS:2||Liver Abscess:2||cDNA microarray:2||candidemia:2||peptidoglycanassociated lipoprotein:2||Empyema:2||Outbreak:2||HIV Infection:2||COVID19:2||communityacquired infections:2||Clostridium difficile:2||computed tomography:2||pulmonary tuberculosis:2||respiratory viruses:2||Infectious arthritis:2||Sepsis:2||Measles:2||EpsteinBarr virus:2||Serotype:2||septic shock:2||diagnosis:2||drug resistance:2||Defined daily dose:1||Diagnosis:1||Digital health care monitoring system:1||Disease Outbreaks:1||Disease transmission:1||Dose interval:1||Drug resistance:1||Dyslipidemia:1||ELISA:1||EMERGENCE:1||EQUAL Candida score:1||Effectiveness:1||Electrochemistry:1||Endogenous fungal endophthalmitis:1||Endophthalmitis:1||Escherichia coli:1||Etiology:1||Evaluation:1||Foodborne outbreaks:1||Fungemia:1||GENNOV:1||Gastroenteriris:1||Gastrointestinal Carriage:1||Gender:1||Glycylcycline:1||Gramnegative bacilli:1||Grampositive bacteria:1||Gummatous neurosyphilis:1||H1N1:1||H1N1 subtype:1||HETERORESISTANCE:1||HHV8:1||HIV infections:1||HIV negative:1||HIVinfected patients:1||HIV/AIDS:1||HOSPITALS:1||Haemothorax:1||Hand washing:1||HanesWoolf plot:1||Hantaan virus:1||Hantann virus:1||Heart valve prosthesis:1||Hemolytic anemia:1||Histiocytic necrotizing lymphadenitis:1||History:1||Homosexuality:1||Hospital:1||Hospital infection control:1||Hospitalacquired:1||Human Immunodeficiency Virus:1||Human immunodeficiency virus:1||Hypervirulent:1||ICUs:1||IDENTIFICATION:1||INFECTION:1||INFECTIONS:1||IS6110:1||IgG avidity:1||Immunocompromised host:1||Immunogenicity:1||Immunosensor:1||Immunosensors:1||Incidence:1||Infection Control:1||Infectious:1||Infective endocarditis:1||Influenza:1||Influenza A:1||Influenza A virus:1||Influenza vaccine:1||Initial therapeutic regimen:1||Insertion sequence 6110:1||Intensive care unit:1||Interrupted timeseries analysis:1||Intraabdominal infection:1||Intraabdominal infection:1||Invasive pneumococcal disease:1||KLEBSIELLATREVISANII:1||KOREA:1||Korea HIV:1||LEGIONELLA PNEUMOPHILA:1||Lactococcus garvieae:1||Lactococcus lactis:1||Latent syphilis:1||Legionella species:1||Legionella speicies:1||Linezolid:1||Liposuction:1||Listeria monocytogenes:1||Liver cirrhosis:1||M. tuberculosis:1||MAMMALIAN CELL:1||MIC:1||MODEL:1||MRSA:1||MWCNTs:1||Macrophage:1||Malignancy:1||Measlesmumpsrubella vaccine:1||MenACYWD:1||Meningococcal vaccine:1||Mepicin:1||Metabolic Complication:1||Metampicillin/sulbactam:1||Metastatic cancer:1||Methicillin Resistance:1||Methicillinresistant:1||Methicillinresistant Staphylococcus aureus (MRSA):1||Methicllinresistant:1||Micafungin:1||Mixedlinker PCR:1||Moleculat typing:1||Mucormycosis:1||Multidrug resistant gram positive cocci:1||Multilocus Sequence Typing:1||Multicenter cohort:1||Multidrug resistance organism:1||Multidrugresistant:1||Multiplex:1||Myocarditis:1||NK/Tcell lymphoma:1||Nanorods:1||National Cohort:1||Necrotising fasciitis:1||Neonate:1||Neuraminidase inhibitors:1||Neutropenia:1||Nosocomial:1||Nosocomial acquisition:1||Novel coronavirus disease 2019 (COVID19):1||Orientia tsutsugamushi:1||Otolaryngology:1||Outbreaks:1||PCR:1||PCV13:1||PHO() MUTANTS:1||PHOSPHATASE:1||PPSV23:1||PRSP:1||PSEUDOMONASVESICULARIS:1||Pandemic:1||Papilledema:1||Pathogens:1||Penicillinresistant S. pneumoniae:1||Peramivir:1||Percutaneous drainage:1||Peripheral blood mononuclear cell:1||Phase 3:1||Piperacillin/tazobactam:1||Plasmapattern:1||Plasmodium falciparum:1||Pneumococcal Conjugate Vaccine:1||Pneumococcal Infections:1||Pneumococcal Pneumonia:1||Pneumococcal Polysaccharide Vaccine:1||Pneumococcal Vaccines:1||Posaconazole:1||Prevention and control:1||Prognostic factors:1||Protease Inhibitor:1||Pseudomonas aeruginosa:1||Pulmonary Hemorrhage:1||Pulmonary embolism:1||Pulmonary hemorrhage:1||Pure red cell aplasia:1||Pyelonephritis:1||Quinolone resistance:1||RIFAMPICIN:1||Racemose:1||Rapid ART:1||Realtime PCR:1||Recurrence:1||Registry:1||Reservoirs:1||Resource:1||Respiratory tract pathogens:1||Respiratory virus:1||Restriction:1||Rhabdomyolysis:1||Rheumatoid arthritis:1||Rifampin:1||Risk Factor:1||Rotavirus:1||SEPTICEMIA:1||SHV12:1||SYNERGY:1||Salmonella enteritidis:1||Salmonella typhi:1||School:1||Seeplex RV assay:1||Selective gut decontamination:1||Seoul virus:1||Septic Shock:1||Septic shock:1||Severe Acute Respiratory Syndrome (SARS):1||Severe Sepsis:1||Severe sepsis:1||Sexually transmitted diseases:1||Staffing:1||Streptococcus agalactiae:1||Streptococcus pneumonioe:1||Streptococcus sanguinis:1||Subarachnoid:1||Suprasellar Tumor:1||Susceptibility:1||Syphilis:1||Tapocin:1||Teicoplanin:1||Therapeutic drug monitoring:1||Thrombophlebitis:1||Time to detection:1||Tolllike receptors:1||Treatment as Prevention:1||Tuberculosis:1||Urinary Tract Infections:1||Urinary tract infection:1||Uveitis:1||VRE:1||Vaccine:1||Vaccines:1||Vancomycin:1||Vancomycin resistance:1||Vancomycinresistant enterococci (VRE):1||Ventilator/nonventilatorassociated pneumonia:1||Vertebral Osteomyelitis:1||Vi capsular polysaccharide typhoid vaccine:1||Zinc oxide:1||adaptive immunity:1||alanine aminotransferase:1||antibacterial agent:1||antibacterial agents:1||antifungal therapy:1||antimicrobial peptide:1||anxiety symptom:1||artesunate:1||aspergillosis:1||avidity:1||babesiosis:1||bacterial drug resistance:1||betalactamases:1||blood cultures:1||blood transfusion:1||bloodstream infections:1||candidaemia:1||casecontrol study:1||cephalosporins:1||cervical lymphadenitis:1||clinical efficacy:1||cloning:1||coinfection:1||colonization:1||combination therapy:1||communityacquired pneumonia:1||coreneedle gun biopsy:1||costeffectiveness analysis:1||cross infection:1||cutaneous infection:1||cytokine:1||cytotoxic Tlymphocyte:1||depressive symptom:1||disseminated candidiasis:1||drug resistance, microbial:1||echinocandin:1||efectrochemiluminescence:1||enterococcus:1||expression:1||falciparum malaria:1||fluconazole:1||gallium scan:1||gastric surgery:1||gene:1||genotype:1||hap1:1||hemolytic anemia:1||hemorrhagic fever with renal syndrome:1||hepatitis A virus:1||human immunodeficiency virus:1||immunity:1||immunochromatographic assay:1||immunoliposome:1||immunoassay:1||immunobiosensor:1||immunocompromised host:1||immunogenecity:1||immunogenicity:1||imported malaria:1||incidence:1||intensive care unit:1||isoleucinetRNA ligase:1||legionella:1||lipoprotein:1||lipoproteins:1||liver cirrhosis:1||lymph nodes:1||macrophages, peritoneal:1||malaria circumsporozoite:1||minimum inhibitory concentration:1||missense:1||morbidity:1||moxifloxacin:1||multiwalled carbon nanotube:1||multidrug resistant:1||multidrugresistant bacteria:1||multilocus sequence typing:1||multiplex:1||mumps:1||mupirocin:1||mutation:1||neck:1||nosocomial infections:1||nucleotide sequence:1||opportunistic infections:1||outbreak:1||outcome:1||outcomes:1||oxygen plasma:1||pathology:1||peptide antibiotics:1||peptide epitope:1||peritonitis:1||plasmid:1||pneumococcal vaccination:1||pneumonia, ventilatorassociated:1||pneumophila:1||pointofcare device:1||poreforming protein:1||predictive model:1||prescription:1||prevalence:1||procalcitonin:1||pulmonary edema:1||pulmonary lymphomatoid granulomatosis:1||reverse transcription PCR:1||risk factor:1||safety:1||screenprinted electrodes:1||sepsis:1||serotyping:1||severe sepsis:1||severity:1||skull base:1||smearnegative:1||smearpositive:1||sphH:1||spine:1||spread:1||sputum:1||survival:1||the Separation of Prescription and Drug Selling:1||timeseries analysis:1||toxic epidermal necrolysis:1||treatment:1||treatment outcome:1||ureteral obstruction:1||vaccine:1||vaccine failure:1||virus culture:1||voriconazole:1||감염경로:1||감염성 심내막염:1||동성애:1||렙토스피라병:1||리팜핀:1||면역반응:1||사망률:1||아나필락시스:1||예후:1||위험인자:1||인간면역결핍바이러스:1||인간면역결핍바이러스 감염:1||중환자실:1||폐출혈:1||피부농양:1||횡문근 융해:1||0000:1||후천면역결핍증:1||23valent pneumococcal vaccine:1||AIDS Cohort Study:1||AIDSrelated opportunistic infections:1||AMPR11:1||ARDS:1||Acinetobacter:1||Acinetobacter baumanii:1||Acinetobacter baumannii:1||Acquired immune deficiency syndrome:1||Acquisition:1||Active surveillance:1||Acute kidney injury:1||Acute pyeolnephritis:1||Adherence:1||Adverse Event:1||Aeromonas:1||Albendazole:1||Amikacin:1||Amphotericin B:1||Anaphylaxis:1||Anemia:1||Anidulafungin:1||Antibacterial agents:1||Antiretroviral agents:1||Antibiotc dose:1||Antibiotic resistance:1||Antibiotic susceptibility:1||Antibiotic use:1||Antigen:1||Antimicrobial:1||Antimicrobial use density:1||Antimicrobial utilization:1||Antiretroviral Therapy:1||Appropriate use of antibiotics:1||Arbitrarily primed polymerase chain reaction (APPCR):1||Asia:1||AsiaPacific region:1||Aspergillosis:1||Autonomic Dysfunction:1||BACTEC:1||BACTEREMIA:1||BacT/Alert:1||Bacteraemia:1||Bacterial:1||Bacterial resistance:1||Baths:1||Biomarker:1||Blood culture:1||BroadSpectrum Antigen:1||Bromocriptine:1||Creactive protein:1||CHILD:1||COLONIZATION:1||COMBNOV:1||COMBINATION:1||Calf:1||Casecontrol studies:1||Casecontrol study:1||Cefditoren:1||Ceftazidime/avibactam:1||Central Fever:1||Chlamydia pneumoniae:1||Chlamydophila pneumoniae:1||Chlorhexidine gluconate:1||Chronic kidney disease:1||Ciprofloxacin:1||Clinical characteristics:1||Clinical efficacy:1||Clinical severity:1||Clinical trial:1||Clostridium septicum:1||Cohort Study:1||Cohort studies:1||Community:1||Community treatment center:1||CommunityAcquired Pneumonia:1||Communityacquired infections:1||Complicated intraabdominal infection:1||Computerbased program:1||Continuity of patient care:1||Control:1||Cooling tower:1||Corticosteroid:1||Corynebacterium striatum:1||Crosssectional study:1||Culture bottle:1||Cysticercosis:1||DHA1:1||DNA vaccine:1||

STATISTICS: Total View :12,808,235; Today View :4,531

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE